• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Definitive Surgical Management of Refractory Amiodarone-Induced Thyrotoxicosis in a Cardiac Patient: A Case Report.一名心脏病患者难治性胺碘酮所致甲状腺毒症的确定性手术治疗:病例报告
Cureus. 2025 May 2;17(5):e83354. doi: 10.7759/cureus.83354. eCollection 2025 May.
2
Surgical Treatment of Amiodarone-Induced Thyrotoxicosis in an Adult with Congenital Heart Disease: An Anesthetists Perspective.成人先天性心脏病患者胺碘酮所致甲状腺毒症的外科治疗:麻醉医师视角
Am J Case Rep. 2020 Feb 6;21:e917350. doi: 10.12659/AJCR.917350.
3
Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.碘番酸在甲状腺切除术之前可迅速控制I型胺碘酮所致甲状腺毒症。
J Endocrinol Invest. 2002 Feb;25(2):176-80. doi: 10.1007/BF03343984.
4
Refractory amiodarone-induced thyrotoxicosis requiring adjunctive cholestyramine treatment.对抗甲状腺素药物胺碘酮诱导的甲状腺功能亢进症需要辅助考来烯胺治疗。
BMJ Case Rep. 2024 Sep 3;17(9):e259860. doi: 10.1136/bcr-2024-259860.
5
Thyroid arterial embolization in a patient with congenital heart disease and refractory amiodarone-induced thyrotoxicosis.先天性心脏病合并难治性胺碘酮所致甲状腺毒症患者的甲状腺动脉栓塞术
Eur Thyroid J. 2022 Jan 1;11(1):e210007. doi: 10.1530/ETJ-21-0007.
6
Surgical management of amiodarone-induced thyrotoxicosis.胺碘酮所致甲状腺毒症的外科治疗
Otolaryngol Head Neck Surg. 2003 Nov;129(5):565-70. doi: 10.1016/s0194-5998(03)01590-0.
7
Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.胺碘酮所致甲状腺毒症:临床表现及甲状腺切除术的扩展适应证
Surgery. 1993 Dec;114(6):1114-9.
8
Amiodarone-induced thyrotoxicosis: a case for surgical management.胺碘酮所致甲状腺毒症:手术治疗的一个病例
Am J Otolaryngol. 2002 Nov-Dec;23(6):358-61. doi: 10.1053/ajot.2002.128042.
9
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy.暴露于甲状腺毒症的时间增加了合并自身免疫性甲状腺炎(AIT)患者的死亡率:甲状腺切除术的作用。
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa464.
10
Successful Pretreatment Using Plasma Exchange before Thyroidectomy in a Patient with Amiodarone-Induced Thyrotoxicosis.胺碘酮所致甲状腺毒症患者甲状腺切除术前采用血浆置换进行预处理成功
Eur Thyroid J. 2017 Apr;6(2):108-112. doi: 10.1159/000453578. Epub 2017 Feb 18.

本文引用的文献

1
2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.2018年欧洲甲状腺协会(ETA)胺碘酮相关性甲状腺功能障碍管理指南。
Eur Thyroid J. 2018 Mar;7(2):55-66. doi: 10.1159/000486957. Epub 2018 Feb 14.
2
Amiodarone and the thyroid: a 2012 update.胺碘酮与甲状腺:2012 年更新
J Endocrinol Invest. 2012 Mar;35(3):340-8. doi: 10.3275/8298. Epub 2012 Mar 19.
3
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.甲状腺功能亢进症及其他原因所致甲状腺毒症:美国甲状腺协会和美国临床内分泌医师学会管理指南。
Thyroid. 2011 Jun;21(6):593-646. doi: 10.1089/thy.2010.0417. Epub 2011 Apr 21.
4
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.胺碘酮所致甲状腺毒症的诊断与管理:北美与欧洲甲状腺专家之间的异同
Clin Endocrinol (Oxf). 2008 Nov;69(5):812-8. doi: 10.1111/j.1365-2265.2008.03268.x. Epub 2008 Apr 10.
5
Successful treatment of amiodarone-induced thyrotoxicosis.胺碘酮所致甲状腺毒症的成功治疗。
Circulation. 2002 Mar 19;105(11):1275-7.

一名心脏病患者难治性胺碘酮所致甲状腺毒症的确定性手术治疗:病例报告

Definitive Surgical Management of Refractory Amiodarone-Induced Thyrotoxicosis in a Cardiac Patient: A Case Report.

作者信息

Shah Islam, Fabricante Jonathan, Vattiyam Veettil Fahas Ali

机构信息

Internal Medicine (General Medicine), District Headquarter Hospital, Daggar, PAK.

Internal Medicine, Khyber Teaching Hospital, Peshawar, PAK.

出版信息

Cureus. 2025 May 2;17(5):e83354. doi: 10.7759/cureus.83354. eCollection 2025 May.

DOI:10.7759/cureus.83354
PMID:40458352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12127699/
Abstract

Amiodarone-induced thyrotoxicosis (AIT) presents a significant therapeutic challenge, particularly in patients with underlying cardiac comorbidities. We present a 58-year-old man with a background history of ischemic heart disease and atrial fibrillation who developed AIT following long-term amiodarone use. Despite the escalation of medical therapy, he remained clinically and biochemically thyrotoxic with symptomatic atrial fibrillation. Definitive management via total thyroidectomy was performed, resulting in clinical stabilization. This case highlights the importance of early multidisciplinary input and the role of total thyroidectomy in managing refractory AIT in high-risk cardiac patients.

摘要

胺碘酮所致甲状腺毒症(AIT)带来了重大的治疗挑战,尤其是在有潜在心脏合并症的患者中。我们报告一名58岁男性,有缺血性心脏病和心房颤动病史,长期使用胺碘酮后发生了AIT。尽管加强了药物治疗,但他在临床和生化指标上仍处于甲状腺毒症状态,并伴有症状性心房颤动。通过甲状腺全切除术进行了确定性治疗,使病情临床稳定。该病例凸显了早期多学科协作的重要性以及甲状腺全切除术在管理高危心脏患者难治性AIT中的作用。